Key result
A higher CHA2DS2-VASc score independently predicted the no-reflow phenomenon in patients with STEMI undergoing primary PCI (OR 3.06, 95% CI 2.23-4.21, P < 0.001).
Why the study?
Does the CHA2DS2-VASc score predict the no-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary PCI?
Population
396 patients with acute ST elevation myocardial infarction (STEMI) who had undergone primary PCI
Design
Cohort
Authors
Loading...
CHA2DS2-VASc score was associated with no-reflow after STEMI PCI; hypothesis-generating and requires prospective validation before clinical use.
Cross-Sectional (n=396)
No
Does the CHA2DS2-VASc score predict the no-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary PCI?
Odds Ratio: 3.06 (95% CI 2.23–4.21)
p-value: p=<0.001
The CHA2DS2-VASc score can serve as a simple, independent predictor of the no-reflow phenomenon in STEMI patients undergoing primary PCI.
Mirbolouk et al. (2018) conducted a cross-sectional in Acute ST-segment elevation myocardial infarction (STEMI) (n=396). CHA2DS2-VASc score vs. Lower CHA2DS2-VASc score was evaluated on No-reflow phenomenon (TIMI flow rate ≤2) (OR 3.06, 95% CI 2.23-4.21, p=<0.001). A higher CHA2DS2-VASc score independently predicted the no-reflow phenomenon in patients with STEMI undergoing primary PCI (OR 3.06, 95% CI 2.23-4.21, P < 0.001).